Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 457193, 10 pages
http://dx.doi.org/10.1155/2015/457193
Research Article

Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways

Department Surgery, Putuo Hospital, University of Traditional Chinese Medicine in Shanghai, Shanghai 200062, China

Received 19 January 2015; Revised 23 May 2015; Accepted 27 May 2015

Academic Editor: Alessandro Passardi

Copyright © 2015 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-C. Wang and J. Li, “An update on chemotherapy of colorectal liver metastases,” World Journal of Gastroenterology, vol. 18, no. 1, pp. 25–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-X. Lu, K.-J. Nan, and Y. Lei, “Agents from amphibians with anticancer properties,” Anti-Cancer Drugs, vol. 19, no. 10, pp. 931–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Qia, A. Li, Y. Inagaki et al., “Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor,” International Immunopharmacology, vol. 11, no. 3, pp. 342–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Meng, P. Yang, Y. Shen et al., “Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer,” Cancer, vol. 115, no. 22, pp. 5309–5318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T.-J. Qin, X.-H. Zhao, J. Yun, L.-X. Zhang, Z.-P. Ruan, and B.-R. Pan, “Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma,” World Journal of Gastroenterology, vol. 14, no. 33, pp. 5210–5216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Miao, L.-L. Bi, X. Li et al., “Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1370–1382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Jiang, Y. Zhang, J. Luan et al., “Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action,” Cytotechnology, vol. 62, no. 6, pp. 573–583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Amano, Y. Cho, M. Matsunawa, K. Komiyama, and M. Makishima, “Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 114, no. 3–5, pp. 144–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Li, X. Qu, K. Hou et al., “PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells,” Anti-Cancer Drugs, vol. 20, no. 1, pp. 59–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-H. Yu, S.-F. Kan, H.-F. Pu, E. J. Chien, and P. S. Wang, “Apoptotic signaling in Bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells,” Cancer Science, vol. 99, no. 12, pp. 2467–2476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Zhu, E. Li, Y. Liu et al., “Inhibition of Jak-STAT3 pathway enhances Bufalin-induced apoptosis in colon cancer SW620 cells,” World Journal of Surgical Oncology, vol. 10, article 228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Y. Fu, D. Theodorescu, R. S. Kerbel, and R. M. Hoffman, “Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice,” International Journal of Cancer, vol. 49, no. 6, pp. 938–939, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Y. Fu, J. M. Besterman, A. Monosov, and R. M. Hoffman, “Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 20, pp. 9345–9349, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Hoffman, “Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic,” Investigational New Drugs, vol. 17, no. 4, pp. 343–359, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Y. Fu and R. M. Hoffman, “Human RT-4 bladder carcinoma is highly metastatic in nude mice and comparable to ras-H-transformed RT-4 when orthotopically onplanted as histologically intact tissue,” International Journal of Cancer, vol. 51, no. 6, pp. 989–991, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhu, E. Li, Y. Liu et al., “Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression,” Acta Haematologica, vol. 128, no. 3, pp. 144–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-Y. Qiu, Q. Hu, Q.-F. Tang et al., “MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis,” Tumor Biology, vol. 35, no. 3, pp. 2599–2606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Numazawa, M.-A. Shinoki, H. Ito, T. Yoshida, and Y. Kuroiwa, “Involvement of Na+,K+-ATPase inhibition in K562 cell differentiation induced by Bufalin,” Journal of Cellular Physiology, vol. 160, no. 1, pp. 113–120, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-Q. Yin, J.-N. Shen, W.-W. Su et al., “Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines,” Acta Pharmacologica Sinica, vol. 28, no. 5, pp. 712–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Takai, T. Ueda, M. Nishida, K. Nasu, and H. Narahara, “Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells,” International Journal of Molecular Medicine, vol. 21, no. 5, pp. 637–643, 2008. View at Google Scholar · View at Scopus
  22. B. C. Giovanella, S. O. Yim, A. C. Morgan, J. S. Stehlin, and L. J. Williams Jr., “Brief communication: metastases of human melanomas transplanted in ‘nude‘ mic,” Journal of the National Cancer Institute, vol. 50, no. 4, pp. 1051–1053, 1973. View at Google Scholar
  23. J. Rygaard and C. O. Povlsen, “Heterotransplantation of a human malignant tumour to ‘Nude’ mice,” Acta pathologica et Microbiologica Scandinavica, vol. 77, no. 4, pp. 758–760, 1969. View at Google Scholar · View at Scopus
  24. D. Guenot, E. Guérin, S. Aguillon-Romain et al., “Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability,” The Journal of Pathology, vol. 208, no. 5, pp. 643–652, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. V. Céspedes, C. Espina, M. A. García-Cabezas et al., “Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites,” American Journal of Pathology, vol. 170, no. 3, pp. 1077–1085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Sasaki, Y. Kitadai, T. Nakamura et al., “Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice,” Neoplasia, vol. 9, no. 12, pp. 1066–1077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-Q. Han, G. Huang, W. Gu, Y.-H. Su, X.-Q. Huang, and C.-Q. Ling, “Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice,” World Journal of Gastroenterology, vol. 13, no. 24, pp. 3374–3379, 2007. View at Google Scholar · View at Scopus
  28. F. Qi, Y. Inagaki, B. Gao et al., “Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways,” Cancer Science, vol. 102, no. 5, pp. 951–958, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. F. B. Furnari, H.-J. Su Huang, and W. K. Cavenee, “The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells,” Cancer Research, vol. 58, no. 22, pp. 5002–5008, 1998. View at Google Scholar · View at Scopus
  30. M. Tamura, J. Gu, K. Matsumoto, S.-I. Aota, R. Parsons, and K. M. Yamada, “Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN,” Science, vol. 280, no. 5369, pp. 1614–1617, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Radu, V. Neubauer, T. Akagi, H. Hanafusa, and M.-M. Georgescu, “PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1,” Molecular and Cellular Biology, vol. 23, no. 17, pp. 6139–6149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. P. Hayes, H. Wang, R. Espinal-Witter et al., “PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia,” Clinical Cancer Research, vol. 12, part 1, no. 20, pp. 5932–5935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. I. T. Koksal, D. Yasar, E. Dirice et al., “Differential PTEN protein expression profiles in superficial versus invasive bladder cancers,” Urologia Internationalis, vol. 75, no. 2, pp. 102–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. G. C. Kaiser, F. Yan, and D. B. Polk, “Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes,” Gastroenterology, vol. 116, no. 3, pp. 602–609, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. C. P. Hsu, T. Y. Kao, W. L. Chang, S. Nieh, H. L. Wang, and Y. C. Chung, “Clinical significance of tumor suppressor PTEN in colorectal carcinoma,” European Journal of Surgical Oncology, vol. 37, no. 2, pp. 140–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Manna and S. K. Jain, “Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Czeta/lambda (PKCzeta/lambda) in 3T3l1 adipocyte,” The Journal of Biological Chemistry, vol. 286, no. 46, pp. 39848–39859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. G. Kennedy, E. S. Kandel, T. K. Cross, and N. Hay, “Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5800–5810, 1999. View at Google Scholar · View at Scopus
  38. H. Yamaguchi and H.-G. Wang, “The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change,” Oncogene, vol. 20, no. 53, pp. 7779–7786, 2001. View at Publisher · View at Google Scholar · View at Scopus